HALOZYME THERAPEUTICS, INC. (HALO) Capital expenditures 2016–2025
HALOZYME THERAPEUTICS, INC. (HALO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$7.0MFY2025 · since FY2016: $3.1M → $7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.0M | -34.8% |
| FY2024 | $10.7M | -30.1% |
| FY2023 | $15.3M | +218.0% |
| FY2022 | $4.8M | +230.1% |
| FY2021 | $1.5M | -41.8% |
| FY2020 | $2.5M | -38.0% |
| FY2019 | $4.0M | -13.4% |
| FY2018 | $4.7M | +245.4% |
| FY2017 | $1.4M | -57.0% |
| FY2016 | $3.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice